NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/17/2026
Back to search
Official data from USPTO
WUKOMNI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
02/17/2026
Trademark type
Combined
Nice classes
5
Filing date
04/11/2025
Registration date
02/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
02/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Wuxi City, Jiangsu, CN
Examiner
ORDOGNE, ROBERT J
Law office
N80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the literal element "WUKOMNI" to the right of a design consisting of two pairs of differing fanciful geometric shapes, two of which are oval shaped and two of which are quadrilateral shaped.
Holders and representatives
Holders
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparations; Antibiotics for human use; Pharmaceutical products for the prevention and treatment of cancer; Dietetic beverages adapted for medical purposes; Vitamin tablets; Dietetic foods for treating autoimmune diseases and cancer; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for cellular therapy for the treatment of autoimmune diseases and cancer; Pharmaceutical preparations for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensiondiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; Pharmaceutical preparations for use in dermatology; Adjuvants for medical purposes; Analgesics; Sterilizing preparations; Medicines made of Chinese traditional medicinal herbs; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Antibacterial pharmaceuticals; Bacterial and bacteriological preparations for medical or veterinary purposes; Biological preparations for the treatment of cancer; Biological reagents for medical purposes; Stem cells for medical purposes; Depuratives for the body; Chemical preparations for sanitary purposes; Antibiotic tablets; Allergy tablets; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Dietetic foods adapted for medical purposes; Nutritional supplements; Enzymes for veterinary purposes; Stem cells for veterinary purposes; Vaccine preparations; Vaccines; Injectable pharmaceuticals for treatment of anaphylactic reactions
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/30/2025
PUBO
PUBLISHED FOR OPPOSITION
12/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/09/2025
GNRT
NON-FINAL ACTION E-MAILED
09/09/2025
CNRT
NON-FINAL ACTION WRITTEN
09/09/2025
DOCK
ASSIGNED TO EXAMINER
09/08/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/22/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/22/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/21/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/21/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/21/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/11/2025
NWAP
NEW APPLICATION ENTERED
04/11/2025
Continuous trademark protection
Get notified about every new filing that threatens WUKOMNI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.